Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX).

Full DD Report for CPIX

You must become a subscriber to view this report.


Recent News from (NASDAQ: CPIX)

Cumberland Pharmaceuticals' (CPIX) CEO A.J. Kazimi on Q1 2018 Results - Earnings Call Transcript
Cumberland Pharmaceuticals Inc. (CPIX) Q1 2018 Results Conference Call May 08, 2018 04:30 PM ET Executives Erin Smith - Corporate Relations A. J. Kazimi - Founder, Chairman, CEO and President Marty Cearnal - Chief Commercial Officer, EVP and Director Michael Bonner - CFO and Se...
Source: SeekingAlpha
Date: May, 12 2018 01:06
Cumberland Pharmaceuticals misses by $0.07, misses on revenue
Cumberland Pharmaceuticals (NASDAQ: CPIX ): Q1 EPS of -$0.09 misses by $0.07 . More news on: Cumberland Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 08 2018 16:35
Cumberland Pharmaceuticals Reports First Quarter 2018 Financial Results
NASHVILLE, Tenn. , May 8, 2018 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology, and oncology supportive care today announced first quarter 2018 financial results. Net revenues for th...
Source: PR Newswire
Date: May, 08 2018 16:05
Cumberland Pharmaceuticals To Announce First Quarter 2018 Financial Results
NASHVILLE, Tenn. , May 1, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2018 financial results after the market closes on Tuesday, May 8 , 2018.  A conference call and live Internet webcast will be held on T...
Source: PR Newswire
Date: May, 01 2018 09:35
Cumberland Pharmaceuticals Expands into Oncology Support
NASHVILLE, Tenn. , April 9, 2018 /PRNewswire/ --  Cumberland Pharmaceuticals – announced today that it has expanded its medical specialties to include oncology-related medications. The company's entry into the oncology specialty includes two initial supportive care medication...
Source: PR Newswire
Date: April, 09 2018 09:00
Newly Published Data Demonstrates 85% Eradication of Ulcer Causing Bacteria
NASHVILLE, Tenn. , March 26, 2018 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a U.S. specialty pharmaceutical company announced today the publication of an open access article in Infection and Drug Resistance , with results demonstrating an 85% eradication rate...
Source: PR Newswire
Date: March, 26 2018 09:35
Cumberland Pharmaceuticals Inc. 2017 Q4 - Results - Earnings Call Slides
The following slide deck was published by Cumberland Pharmaceuticals Inc. in conjunction with their 2017 Q4 earnings Read more ...
Source: SeekingAlpha
Date: March, 07 2018 23:47
Cumberland Pharmaceuticals' (CPIX) CEO A.J. Kazimi on Q4 2017 Results - Earnings Call Transcript
Cumberland Pharmaceuticals Inc. (CPIX) Q4 2017 Earnings Conference Call March 06, 2018, 04:30 AM ET Executives Erin Smith - Corporate Relations A. J. Kazimi - Founder, Chairman, CEO and President Martin Cearnal - Chief Commercial Officer, EVP and Director Michael Bonner - CFO a...
Source: SeekingAlpha
Date: March, 06 2018 22:04
Cumberland Pharmaceuticals Reports 25% Revenue Growth For The Full Year 2017
NASHVILLE, Tenn. , March 6, 2018 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology, and oncology supportive care today announced fourth quarter and full year 2017 financial results....
Source: PR Newswire
Date: March, 06 2018 16:05
Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2017 Financial Results
NASHVILLE, Tenn. , Feb. 27, 2018 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release fourth quarter and annual 2017 financial results after the market closes on Tuesday, March 6 , 2018.  A conference call and live Internet we...
Source: PR Newswire
Date: February, 27 2018 16:05

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-135.925.856.51535.772612,907
2018-08-105.805.905.905.802,733
2018-08-095.855.815.905.662,397
2018-08-085.955.95345.95345.61210,574
2018-08-076.005.756.005.512,606

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-13600600100.0000Short
2018-08-084003,60911.0834Cover
2018-08-074741,26937.3522Short
2018-08-066642,09131.7551Cover
2018-08-0310099710.0301Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CPIX.


About Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX)

Logo for Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $92,661,948 - 05/15/2018
  • Issue and Outstanding: 15,652,356 - 03/06/2018

 


Recent Filings from (NASDAQ: CPIX)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 16 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: March, 15 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 09 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 09 2018

 

 


Daily Technical Chart for (NASDAQ: CPIX)

Daily Technical Chart for (NASDAQ: CPIX)


Stay tuned for daily updates and more on (NASDAQ: CPIX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CPIX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CPIX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of CPIX and does not buy, sell, or trade any shares of CPIX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/